Clinical Trials Directory

Trials / Completed

CompletedNCT03552289

Cook Enforcer Post-Market Study

Randomized Clinical Study to Evaluate the Advance® Enforcer™ 35 Focal-Force PTA Balloon Catheter in Treatment of Arteriovenous Dialysis Access Circuit Stenosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
211 (actual)
Sponsor
Cook Research Incorporated · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the performance of the Cook Advance® Enforcer™ 35 Focal-Force PTA Balloon Catheter (or Enforcer balloon) in treating narrowed blood vessels compared to treatment with a conventional angioplasty balloon.

Conditions

Interventions

TypeNameDescription
DEVICECook Advance® Enforcer 35 Focal-Force Percutaneous Transluminal Angioplasty (PTA) Balloon CatheterThe Enforcer balloon device will be used in treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistula
DEVICEConventional angioplasty balloon cathetersCommercially available angioplasty balloon devices will be used in treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistula

Timeline

Start date
2018-08-07
Primary completion
2019-05-29
Completion
2019-08-27
First posted
2018-06-11
Last updated
2020-10-19
Results posted
2020-08-24

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03552289. Inclusion in this directory is not an endorsement.